Cancer Gene Therapy
<em>Cancer Gene Therapy</em> is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair. <em>Cancer Gene Therapy</em> publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Articles published include the fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.
http://feeds.nature.com/cgt/rss/current
Nature Publishing Group
en
© 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Cancer Gene Therapy
© 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
permissions@nature.com
Cancer Gene Therapy
https://www.nature.com/uploads/product/cgt/rss.png
http://feeds.nature.com/cgt/rss/current
-
https://www.nature.com/articles/s41417-024-00752-0
Cancer Gene Therapy, Published online: 28 March 2024; doi:10.1038/s41417-024-00752-0Gastrointestinal infections and gastrointestinal haemorrhage are underestimated but serious adverse events in chimeric antigen receptor T-cell recipients: A real-world study]]>
Zhiqiang SongYang WangPing LiuYuke GengNa LiuJie ChenJianmin Yang
doi:10.1038/s41417-024-00752-0
Cancer Gene Therapy, Published online: 2024-03-28; | doi:10.1038/s41417-024-00752-0
2024-03-28
Cancer Gene Therapy
10.1038/s41417-024-00752-0
https://www.nature.com/articles/s41417-024-00752-0
-
https://www.nature.com/articles/s41417-024-00756-w
Cancer Gene Therapy, Published online: 26 March 2024; doi:10.1038/s41417-024-00756-wEnhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer]]>
Masanori OshiArya Mariam RoyLi YanSachika KinoshitaYuko TamuraTakashi KosakaHirotoshi AkiyamaChikara KunisakiKazuaki TakabeItaru Endo
doi:10.1038/s41417-024-00756-w
Cancer Gene Therapy, Published online: 2024-03-26; | doi:10.1038/s41417-024-00756-w
2024-03-26
Cancer Gene Therapy
10.1038/s41417-024-00756-w
https://www.nature.com/articles/s41417-024-00756-w
-
https://www.nature.com/articles/s41417-024-00761-z
Cancer Gene Therapy, Published online: 18 March 2024; doi:10.1038/s41417-024-00761-zHippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers]]>
Hongge LiangYan XuJing ZhaoMinjiang ChenMengzhao Wang
doi:10.1038/s41417-024-00761-z
Cancer Gene Therapy, Published online: 2024-03-18; | doi:10.1038/s41417-024-00761-z
2024-03-18
Cancer Gene Therapy
10.1038/s41417-024-00761-z
https://www.nature.com/articles/s41417-024-00761-z
-
https://www.nature.com/articles/s41417-024-00764-w
Cancer Gene Therapy, Published online: 18 March 2024; doi:10.1038/s41417-024-00764-wHeterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications]]>
Fatema SafriRomario NguyenShadi ZerehpooshnesfchiJacob GeorgeLiang Qiao
doi:10.1038/s41417-024-00764-w
Cancer Gene Therapy, Published online: 2024-03-18; | doi:10.1038/s41417-024-00764-w
2024-03-18
Cancer Gene Therapy
10.1038/s41417-024-00764-w
https://www.nature.com/articles/s41417-024-00764-w
-
https://www.nature.com/articles/s41417-024-00763-x
Cancer Gene Therapy, Published online: 16 March 2024; doi:10.1038/s41417-024-00763-xThe pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers]]>
Domenica RonchettiValentina TrainiIlaria SilvestrisGiuseppina FabbianoFrancesco PassamontiNiccolò BolliElisa Taiana
doi:10.1038/s41417-024-00763-x
Cancer Gene Therapy, Published online: 2024-03-16; | doi:10.1038/s41417-024-00763-x
2024-03-16
Cancer Gene Therapy
10.1038/s41417-024-00763-x
https://www.nature.com/articles/s41417-024-00763-x
-
https://www.nature.com/articles/s41417-024-00759-7
Cancer Gene Therapy, Published online: 14 March 2024; doi:10.1038/s41417-024-00759-7MISEV2023: Shaping the Future of EV Research by Enhancing Rigour, Reproducibility and Transparency]]>
Mark SamuelsGeorgios Giamas
doi:10.1038/s41417-024-00759-7
Cancer Gene Therapy, Published online: 2024-03-14; | doi:10.1038/s41417-024-00759-7
2024-03-14
Cancer Gene Therapy
10.1038/s41417-024-00759-7
https://www.nature.com/articles/s41417-024-00759-7
-
https://www.nature.com/articles/s41417-024-00753-z
Cancer Gene Therapy, Published online: 13 March 2024; doi:10.1038/s41417-024-00753-zCaffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT]]>
Ying-Yu KuoChieh HuoChia-Yang LiChih-Pin Chuu
doi:10.1038/s41417-024-00753-z
Cancer Gene Therapy, Published online: 2024-03-13; | doi:10.1038/s41417-024-00753-z
2024-03-13
Cancer Gene Therapy
10.1038/s41417-024-00753-z
https://www.nature.com/articles/s41417-024-00753-z
-
https://www.nature.com/articles/s41417-024-00751-1
Cancer Gene Therapy, Published online: 13 March 2024; doi:10.1038/s41417-024-00751-1Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis]]>
Marcela S. WernerShweta ArasAshleigh R. MorganJillian RoamerNesteene J. ParamKanyin OlagbegiR. Jason LamontagneJenny A. GreigJames M. Wilson
doi:10.1038/s41417-024-00751-1
Cancer Gene Therapy, Published online: 2024-03-13; | doi:10.1038/s41417-024-00751-1
2024-03-13
Cancer Gene Therapy
10.1038/s41417-024-00751-1
https://www.nature.com/articles/s41417-024-00751-1